Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2026-01-01 @ 11:47 PM
Study NCT ID:
NCT01053832
Status:
COMPLETED
Last Update Posted:
2011-10-25
First Post:
2010-01-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ventricular Pace Suppression Study
Sponsor:
Biotronik SE & Co. KG
Organization:
Study Overview
Official Title:
Ventricular Pace Suppression Study With the EVIA/ENTOVIS DR-T/DR Pacemaker
Status:
COMPLETED
Status Verified Date:
2011-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VpS
Brief Summary:
Investigation of the efficacy and safety of the Ventricular Pace Suppression (VpS) algorithm.
Detailed Description:
The aim of this study is to investigate the percentage of reduction of ventricular pacing using the VpS feature of the EVIA/ENTOVIS pacemaker in a controlled clinical investigation.
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: